Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

An effective treatment using an effective care delivery model: Using telehealth to treat adolescents with obesity with GLP-1 medications

Karla Lester, MD
Conditions
June 7, 2025
Share
Tweet
Share

Will a telehealth model effectively engage adolescents with obesity and their parents to participate in their treatment plan?

Do GLP-1 agonist medications work to improve weight status and reduce or eliminate comorbidities in adolescents?

I’ve worked for over two decades as a community pediatrician to address the childhood and adolescent obesity epidemic. I can say with full certainty, when it comes to adolescents, we aren’t getting anywhere. With the COVID-19 pandemic, the rates of adolescents with obesity, eating disorders, mental health diagnoses, and health disparities have increased. It’s imperative that we adopt a new approach.

As a medical director of a weight management program at a children’s hospital, I found it was difficult to engage adolescents due to high attrition, low program adherence, and low attendance rates. There were no effective treatments offered other than bariatric surgery, but it is drastic and not feasible for most adolescent patients. When I was told to refer adolescents to the bariatric pathway at their first visit, I knew my values and vision didn’t align with a corporate profit-only driven system.

Approximately 14.4 million U.S. children and adolescents have obesity.1 The TODAY Study showed the incidence of type 2 diabetes in youth increased in parallel with obesity.2 In 2022, the FDA approved once-weekly semaglutide for adolescents with obesity.3

In 2023, the AAP released the Clinical Practice Guidelines (CPG) for the evaluation and treatment of children and adolescents with obesity.4 Pediatricians are called to integrate: Comprehensive obesity treatment; comprehensive patient history; family-based treatment; Intensive Health Behavior and Lifestyle Treatment (IHBLT); and longitudinal care.

Due to lack of obesity training, time, and minimal reimbursement for obesity services, it is not feasible for most pediatricians to implement the AAP Clinical Practice Guidelines. Many pediatricians will not prescribe GLP-1 medications for adolescents because of lack of experience and the time it takes to write prior authorizations and file appeals. Access issues should also include the lack of physicians who prescribe GLP-1 medications for adolescents.

When clinical obesity programs are available within communities, there are barriers that impact outcomes. Weight stigma, time out of school and work, and travel distance result in poor patient retention in clinical obesity programs.5 A telehealth model has potential to mitigate some of the barriers to treatment and improve weight management outcomes for children and adolescents.

Methods

To address access and to determine positive treatment outcomes, I founded Metabolic Telehealth for children and adolescents ages 5 to 21 years in 2022. The practice is licensed in 15 states. The model includes initial telehealth consultation, follow-up appointments, and medication checks. Initial consultation includes a comprehensive patient history and a treatment plan. The Health Yourself group coaching course supports family-centered behavior change as the IHBLT component. Program evaluation is measured using a database to evaluate demographics, accessibility, and treatment outcomes.

Results

Demographics:

  • Of the 44 patients seen for consultation, 34 percent are from rural areas (population less than 10,000). 77 percent of patients identify as female and 23 percent identify as male.
  • Of the different classes of obesity: 43 percent Class I obesity (BMI 30–34.9), 21 percent Class II obesity (BMI 35–39.9), and 16 percent Class III or severe obesity (BMI 40 or higher).
  • 7 percent of patients had a BMI of 27 to 30 with a comorbidity, meeting the FDA criteria for prescribing semaglutide.
  • The most common comorbidities are prediabetes and dyslipidemia.

Accessibility:

  • 34 percent had one visit; 20 percent had two visits; 46 percent had three or more visits.

Treatment/outcomes:

  • 38 (86.4 percent) patients were prescribed GLP-1.
  • 20 of the 38 (53 percent) prior authorizations were denied by their insurance plan.
  • 11 of the 20 denied (55 percent) opted to pay out of pocket for the GLP-1 medication.
  • 20 patients with GLP-1 had three or more follow-up visits.
  • 6 (30 percent) patients on GLP-1 had 20 percent or more BMI reduction.
  • 4 (20 percent) had between 10 and 20 percent BMI reduction.
  • 9 (45 percent) had between 1 to 10 percent BMI reduction.
  • 1 (5 percent) patient increased BMI.

Almost all patients are managed on semaglutide. One patient has been treated with tirzepatide. The two most common side effects are nausea and constipation. Follow-up laboratory data is currently being gathered to determine reduction of comorbidities.

Conclusion

ADVERTISEMENT

There is a need to develop novel approaches to treat children and adolescents with obesity and comorbidities. A telehealth model shows that barriers to treatment are reduced, weight status is improved, and comorbidities are reduced. The limitations with telehealth are that measurement of vital signs is self-reported and the physical examination is limited. The benefits showing improved health far outweigh the limitations.

Telehealth decreases weight stigma, a key factor when helping adolescents struggling with obesity and insulin resistance.

GLP-1 agonist medications are effective medications to treat adolescents with obesity and insulin resistance. They are not a singular fix, but should be considered an adjunct in the treatment plan which also includes nutrition, physical activity, behavior, and other medications. Long-term risk of use of the medications has not been studied in adolescents.

Future questions to study:

  • Are there harms that are caused by treating adolescents with GLP-1 agonist medications?
  • What are the obstacles to access?
  • What are the ethical considerations of starting a potentially lifelong medication in an adolescent?

I do not prescribe compounded GLP-1 medications for adolescent patients. I have no conflicts with the pharmaceutical industry to disclose.

Karla Lester is a pediatrician, certified life and weight coach, and diplomate, American Board of Obesity Medicine. She is founder, IME Community, and can be reached on Twitter @DrKarlaA, TikTok, Instagram @ime_community, Facebook, and YouTube.

Dr. Karla is a child health advocate who has worked to address the childhood obesity epidemic for two decades on local, state, and national levels. Her vision is “creating community with compassionate connection.” She is a poet, an author of a children’s book, The Magical Everywhere, the poem, “Miracle of Will,” in JAMA, and is the grateful mom of three amazing young people.

Find Dr. Karla on TikTok, where she is disrupting the status quo in health care.

Prev

How the 10th Apple Effect is stealing your joy in medicine

June 7, 2025 Kevin 1
…
Next

How doctors can stop frivolous lawsuits before they start

June 7, 2025 Kevin 0
…

Tagged as: Endocrinology

Post navigation

< Previous Post
How the 10th Apple Effect is stealing your joy in medicine
Next Post >
How doctors can stop frivolous lawsuits before they start

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Karla Lester, MD

  • GLP-1 medications like Wegovy are effective metabolic health tools for teens with insulin resistance

    Karla Lester, MD
  • The epidemic of narcissistic abuse in the medical field

    Karla Lester, MD
  • Surviving a manipulative CEO: my experience with gaslighting

    Karla Lester, MD

Related Posts

  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The ritual of taking medications: the pill wheel

    Fery Pashang, PharmD
  • Are letters of recommendation effective or burdensome?

    Catherine Tawfik
  • Are you storing your medications wrong?

    Dr. Farees Ahmad Khan & Dr. Sarah Alnaher
  • Breaking down the barriers to effective bar-code medication administration

    Amy Dang Craft
  • Too many older adults are taking risky sedative medications

    Wendy Levinson, MD and Christine Soong, MD

More in Conditions

  • Earwax could hold secrets to cancer, Alzheimer’s, and heart disease

    Sandra Vamos, EdD and Domenic Alaimo
  • Why male fertility needs to be part of every health conversation

    Hoag Memorial Hospital Presbyterian
  • Why health care must adapt to meet the needs of older adults with disabilities

    Lynn A. Schaefer, PhD
  • 4 traits every new attending physician needs to thrive

    Sarah Epstein
  • When the diagnosis is personal: What my mother’s Alzheimer’s taught me about healing

    Pearl Jones, MD
  • Why local cardiac CT scans could save your life

    Benjamin Cohen, MD
  • Most Popular

  • Past Week

    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
    • When the diagnosis is personal: What my mother’s Alzheimer’s taught me about healing

      Pearl Jones, MD | Conditions
    • Key strategies for smooth EHR transitions in health care

      Sandra Johnson | Tech
    • Reassessing the impact of CDC’s opioid guidelines on chronic pain care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why shared decision-making in medicine often fails

      M. Bennet Broner, PhD | Conditions
  • Recent Posts

    • Why what doctors say matters more than you think [PODCAST]

      The Podcast by KevinMD | Podcast
    • How Mark Twain would dismantle today’s flawed medical AI

      Neil Baum, MD and Mark Ibsen, MD | Tech
    • Mastering medical presentations: Elevating your impact

      Harvey Castro, MD, MBA | Physician
    • Marketing as a clinician isn’t about selling. It’s about trust.

      Kara Pepper, MD | Physician
    • Graduating from medical school without family: a story of strength and survival

      Anonymous | Education
    • Inside human trafficking: a guide to recognizing and preventing it [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
    • When the diagnosis is personal: What my mother’s Alzheimer’s taught me about healing

      Pearl Jones, MD | Conditions
    • Key strategies for smooth EHR transitions in health care

      Sandra Johnson | Tech
    • Reassessing the impact of CDC’s opioid guidelines on chronic pain care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why shared decision-making in medicine often fails

      M. Bennet Broner, PhD | Conditions
  • Recent Posts

    • Why what doctors say matters more than you think [PODCAST]

      The Podcast by KevinMD | Podcast
    • How Mark Twain would dismantle today’s flawed medical AI

      Neil Baum, MD and Mark Ibsen, MD | Tech
    • Mastering medical presentations: Elevating your impact

      Harvey Castro, MD, MBA | Physician
    • Marketing as a clinician isn’t about selling. It’s about trust.

      Kara Pepper, MD | Physician
    • Graduating from medical school without family: a story of strength and survival

      Anonymous | Education
    • Inside human trafficking: a guide to recognizing and preventing it [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...